Dexcom stock plunged to a four-month low Monday after the Food and Drug Administration issued the diabetes devices maker a warning letter tied to inspections of two facilities in the U.S. The warning ...
DexCom (NASDAQ:DXCM) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below provides a snapshot of their recent ratings, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results